Key Insights
The US diabetes devices market, valued at $25.16 billion in 2025, is projected to experience robust growth, driven by a rising prevalence of diabetes, an aging population, and increasing demand for advanced monitoring and management technologies. The market's Compound Annual Growth Rate (CAGR) of 6.27% from 2025 to 2033 indicates significant expansion opportunities. Key growth drivers include the increasing adoption of continuous glucose monitoring (CGM) systems offering real-time glucose data, the rising preference for insulin pumps and pen injectors for improved insulin delivery, and technological advancements leading to more user-friendly and accurate devices. Market segmentation reveals substantial contributions from lancets, insulin pumps, infusion sets (including syringes, cartridges, and disposable pens), and self-monitoring blood glucose (SMBG) devices. The competitive landscape is characterized by established players like Abbott, Medtronic, Dexcom, Novo Nordisk, and Sanofi, alongside emerging companies introducing innovative solutions. Regional analysis, focusing on the United States, suggests variations in market penetration across different regions (Northeast, Southeast, Midwest, Southwest, and West), influenced by factors such as healthcare infrastructure, access to advanced technologies, and diabetes prevalence rates within each region.
Continued growth in the US diabetes devices market is anticipated due to several factors. The increasing focus on diabetes management and prevention initiatives by healthcare providers and government agencies will drive demand for advanced devices. Furthermore, technological advancements, such as the development of integrated systems combining CGM and insulin delivery, and the emergence of artificial pancreas systems, will fuel market expansion. However, high device costs, limited insurance coverage, and potential challenges in device usability for certain patient populations may present constraints to market growth. The market will likely see increased competition, with companies focusing on product differentiation, technological innovation, and strategic partnerships to secure a stronger market position. Therefore, a comprehensive understanding of market trends, regulatory landscape, and consumer preferences will be crucial for success in this dynamic market.
US Diabetes Devices Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the dynamic US Diabetes Devices Market, offering invaluable insights for industry stakeholders, investors, and researchers. With a study period spanning 2019-2033, a base year of 2025, and a forecast period of 2025-2033, this report delivers a holistic view of past performance, current market dynamics, and future growth projections. The market is segmented by device type (Continuous Glucose Monitoring (CGM), Self-Monitoring Blood Glucose (SMBG), Insulin Delivery Systems), covering key players, market trends, and significant regulatory developments. Expected market value is xx Million in 2025.
US Diabetes Devices Market Structure & Competitive Landscape
The US diabetes devices market is characterized by a moderately concentrated structure, with a few key players holding significant market share. The Herfindahl-Hirschman Index (HHI) for 2024 is estimated at xx, indicating a moderately competitive landscape. Innovation is a key driver, fueled by advancements in CGM technology, miniaturization of insulin delivery systems, and the development of integrated solutions. Stringent regulatory oversight by the FDA significantly impacts market entry and product development, fostering a focus on safety and efficacy. Substitutes for certain devices are limited, especially for insulin delivery, although SMBG devices face some competition from CGM systems. The end-user segmentation is primarily composed of patients with type 1 and type 2 diabetes, as well as healthcare providers. Mergers and acquisitions (M&A) activity has been moderate in recent years, with xx M&A deals recorded between 2019 and 2024, primarily focused on strengthening product portfolios and expanding market reach.
- Market Concentration: Moderately concentrated, HHI (2024) estimated at xx.
- Innovation Drivers: Advancements in CGM, miniaturization of insulin delivery systems, integrated solutions.
- Regulatory Impacts: Stringent FDA regulations influence market entry and product development.
- Product Substitutes: Limited substitutes for insulin delivery; SMBG facing competition from CGM.
- End-User Segmentation: Patients with type 1 & type 2 diabetes, healthcare providers.
- M&A Trends: Moderate activity (xx deals 2019-2024), focused on portfolio strengthening and expansion.
US Diabetes Devices Market Market Trends & Opportunities
The US diabetes devices market is experiencing robust growth, driven by increasing prevalence of diabetes, rising demand for advanced CGM systems, and growing adoption of insulin pump therapy. The market is projected to register a CAGR of xx% during the forecast period (2025-2033), reaching an estimated value of xx Million by 2033. Technological advancements, such as the development of integrated CGM-insulin pump systems and artificial pancreas systems, are transforming the market. Consumer preferences are shifting towards user-friendly, accurate, and minimally invasive devices. The market is characterized by intense competition, with established players and emerging companies vying for market share through product innovation, strategic partnerships, and technological advancements. Market penetration rates for CGM are increasing, while SMBG devices remain prevalent, particularly in developing countries.
Dominant Markets & Segments in US Diabetes Devices Market
The dominant segment within the US diabetes devices market is Continuous Glucose Monitoring (CGM) devices, driven by improvements in accuracy, ease of use, and integration with insulin delivery systems. The leading region is the US due to high prevalence of diabetes, robust healthcare infrastructure, and high consumer spending on healthcare.
- Key Growth Drivers for CGM:
- Increasing prevalence of diabetes.
- Growing awareness of the benefits of continuous glucose monitoring.
- Technological advancements (accuracy, ease of use, integration).
- Favorable reimbursement policies.
- Key Growth Drivers for Insulin Delivery Systems:
- Rising adoption of insulin pump therapy.
- Development of closed-loop systems and artificial pancreas.
- Improved patient outcomes.
- Key Growth Drivers for SMBG:
- Lower cost compared to CGM.
- Wider availability.
The US market dominates due to a high diabetes prevalence, advanced healthcare infrastructure, and strong regulatory support for new technologies. Other segments (Insulin Pumps, SMBG, etc.) are growing but at a slower rate compared to CGM.
US Diabetes Devices Market Product Analysis
The US diabetes devices market showcases a diverse range of products, including CGM systems (e.g., Dexcom G7, Abbott FreeStyle Libre), insulin pumps (e.g., Omnipod, Medtronic Minimed), insulin delivery pens, and SMBG devices (e.g., LifeScan OneTouch Ultra). Technological advancements such as improved sensor accuracy, smaller device sizes, and wireless connectivity are enhancing product features and improving patient outcomes. Integration of devices is a significant trend, leading to more seamless management of diabetes. Market fit is strong for convenient, accurate, and affordable devices.
Key Drivers, Barriers & Challenges in US Diabetes Devices Market
Key Drivers:
- Rising Diabetes Prevalence: The increasing incidence of type 1 and type 2 diabetes is driving demand for advanced management solutions.
- Technological Advancements: Continuous innovation in CGM, insulin delivery, and data management technologies.
- Favorable Reimbursement Policies: Increased insurance coverage for advanced devices is boosting affordability and accessibility.
Key Barriers and Challenges:
- High Device Costs: The expense of advanced devices remains a barrier to access for many patients.
- Supply Chain Disruptions: Global supply chain challenges can affect the availability of components and finished products.
- Regulatory Hurdles: The stringent FDA approval process can delay the market entry of innovative devices. This impacts innovation and timely availability.
Growth Drivers in the US Diabetes Devices Market Market
The market’s growth is propelled by technological advancements leading to smaller, more accurate, and user-friendly devices. Increased government initiatives and insurance coverage are crucial in improving affordability and accessibility. The rising prevalence of diabetes itself fuels significant demand.
Challenges Impacting US Diabetes Devices Market Growth
High costs, complex regulatory pathways, and supply chain volatility are major challenges. Competition among numerous players can also impact pricing and market penetration of individual devices.
Key Players Shaping the US Diabetes Devices Market Market
- Omnipod
- Insulin Devices (Multiple Companies)
- Dexcom
- Becton and Dickenson
- Abbott
- F Hoffmann-La Roche AG
- Novo Nordisk
- Medtronic
- Self-monitoring Blood Glucose Devices (Multiple Companies)
- LifeScan
- Sanofi
- Johnson & Johnson
- Ypsomed Holding
- Tandem
- Insulet Corporation
- Eli Lilly and Company
Significant US Diabetes Devices Market Industry Milestones
- August 2023: FDA clearance for Roche's Accu-Chek Solo micropump system – signifies advancement in insulin delivery technology.
- March 2022: Dexcom G7 launch in the UK (pending FDA approval for US release) – demonstrates ongoing innovation in CGM technology.
Future Outlook for US Diabetes Devices Market Market
The US diabetes devices market is poised for continued growth, driven by ongoing technological innovation, rising diabetes prevalence, and increasing healthcare expenditure. Strategic partnerships, new product launches, and expansion into underserved markets will further drive expansion. The development of closed-loop systems and integrated solutions offers significant opportunities for market players.
US Diabetes Devices Market Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose
- 1.1.1. Glucometer Devices
- 1.1.2. Blood Glucose Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring
- 1.2.1. Sensors
- 1.2.2. Durables
-
1.1. Self-monitoring Blood Glucose
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Cartridges in Reusable pens
- 2.4. Insulin Disposable Pens
- 2.5. Jet Injectors
-
2.1. Insulin Pump
US Diabetes Devices Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
US Diabetes Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 6.27% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Procedures
- 3.4. Market Trends
- 3.4.1. Growing Diabetes and Obesity Population in the United States
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Blood Glucose Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring
- 5.1.2.1. Sensors
- 5.1.2.2. Durables
- 5.1.1. Self-monitoring Blood Glucose
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Cartridges in Reusable pens
- 5.2.4. Insulin Disposable Pens
- 5.2.5. Jet Injectors
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. North America US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Blood Glucose Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Glucose Monitoring
- 6.1.2.1. Sensors
- 6.1.2.2. Durables
- 6.1.1. Self-monitoring Blood Glucose
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Cartridges in Reusable pens
- 6.2.4. Insulin Disposable Pens
- 6.2.5. Jet Injectors
- 6.2.1. Insulin Pump
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. South America US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Blood Glucose Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Glucose Monitoring
- 7.1.2.1. Sensors
- 7.1.2.2. Durables
- 7.1.1. Self-monitoring Blood Glucose
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Cartridges in Reusable pens
- 7.2.4. Insulin Disposable Pens
- 7.2.5. Jet Injectors
- 7.2.1. Insulin Pump
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Europe US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Blood Glucose Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Glucose Monitoring
- 8.1.2.1. Sensors
- 8.1.2.2. Durables
- 8.1.1. Self-monitoring Blood Glucose
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Cartridges in Reusable pens
- 8.2.4. Insulin Disposable Pens
- 8.2.5. Jet Injectors
- 8.2.1. Insulin Pump
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Middle East & Africa US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Blood Glucose Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Glucose Monitoring
- 9.1.2.1. Sensors
- 9.1.2.2. Durables
- 9.1.1. Self-monitoring Blood Glucose
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Cartridges in Reusable pens
- 9.2.4. Insulin Disposable Pens
- 9.2.5. Jet Injectors
- 9.2.1. Insulin Pump
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. Asia Pacific US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Blood Glucose Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Glucose Monitoring
- 10.1.2.1. Sensors
- 10.1.2.2. Durables
- 10.1.1. Self-monitoring Blood Glucose
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Cartridges in Reusable pens
- 10.2.4. Insulin Disposable Pens
- 10.2.5. Jet Injectors
- 10.2.1. Insulin Pump
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Northeast US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 12. Southeast US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 13. Midwest US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 14. Southwest US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 15. West US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 1 Omnipod
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Insulin Devices
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 4 Other Continuous Glucose Monitoring Devices
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 3 LifeScan
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 1 Dexcom
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 Becton and Dickenson
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 3 Abbott
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 F Hoffmann-La Roche AG
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 2 Novo Nordisk
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 2 Medtronic
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.11 4 Other Self-monitoring Blood Glucose Devices
- 16.2.11.1. Overview
- 16.2.11.2. Products
- 16.2.11.3. SWOT Analysis
- 16.2.11.4. Recent Developments
- 16.2.11.5. Financials (Based on Availability)
- 16.2.12 Abbott
- 16.2.12.1. Overview
- 16.2.12.2. Products
- 16.2.12.3. SWOT Analysis
- 16.2.12.4. Recent Developments
- 16.2.12.5. Financials (Based on Availability)
- 16.2.13 Self-monitoring Blood Glucose Devices
- 16.2.13.1. Overview
- 16.2.13.2. Products
- 16.2.13.3. SWOT Analysis
- 16.2.13.4. Recent Developments
- 16.2.13.5. Financials (Based on Availability)
- 16.2.14 Novo Nordisk
- 16.2.14.1. Overview
- 16.2.14.2. Products
- 16.2.14.3. SWOT Analysis
- 16.2.14.4. Recent Developments
- 16.2.14.5. Financials (Based on Availability)
- 16.2.15 Eli Lilly and Company*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
- 16.2.15.1. Overview
- 16.2.15.2. Products
- 16.2.15.3. SWOT Analysis
- 16.2.15.4. Recent Developments
- 16.2.15.5. Financials (Based on Availability)
- 16.2.16 Sanofi
- 16.2.16.1. Overview
- 16.2.16.2. Products
- 16.2.16.3. SWOT Analysis
- 16.2.16.4. Recent Developments
- 16.2.16.5. Financials (Based on Availability)
- 16.2.17 Johnson & Johnson
- 16.2.17.1. Overview
- 16.2.17.2. Products
- 16.2.17.3. SWOT Analysis
- 16.2.17.4. Recent Developments
- 16.2.17.5. Financials (Based on Availability)
- 16.2.18 Ypsomed Holding
- 16.2.18.1. Overview
- 16.2.18.2. Products
- 16.2.18.3. SWOT Analysis
- 16.2.18.4. Recent Developments
- 16.2.18.5. Financials (Based on Availability)
- 16.2.19 Medtronic
- 16.2.19.1. Overview
- 16.2.19.2. Products
- 16.2.19.3. SWOT Analysis
- 16.2.19.4. Recent Developments
- 16.2.19.5. Financials (Based on Availability)
- 16.2.20 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 16.2.20.1. Overview
- 16.2.20.2. Products
- 16.2.20.3. SWOT Analysis
- 16.2.20.4. Recent Developments
- 16.2.20.5. Financials (Based on Availability)
- 16.2.21 2 F Hoffmann-La Roche AG
- 16.2.21.1. Overview
- 16.2.21.2. Products
- 16.2.21.3. SWOT Analysis
- 16.2.21.4. Recent Developments
- 16.2.21.5. Financials (Based on Availability)
- 16.2.22 3 Johnson & Johnson
- 16.2.22.1. Overview
- 16.2.22.2. Products
- 16.2.22.3. SWOT Analysis
- 16.2.22.4. Recent Developments
- 16.2.22.5. Financials (Based on Availability)
- 16.2.23 Dexcom
- 16.2.23.1. Overview
- 16.2.23.2. Products
- 16.2.23.3. SWOT Analysis
- 16.2.23.4. Recent Developments
- 16.2.23.5. Financials (Based on Availability)
- 16.2.24 1 Abbott
- 16.2.24.1. Overview
- 16.2.24.2. Products
- 16.2.24.3. SWOT Analysis
- 16.2.24.4. Recent Developments
- 16.2.24.5. Financials (Based on Availability)
- 16.2.25 Continuous Glucose Monitoring Devices
- 16.2.25.1. Overview
- 16.2.25.2. Products
- 16.2.25.3. SWOT Analysis
- 16.2.25.4. Recent Developments
- 16.2.25.5. Financials (Based on Availability)
- 16.2.26 Tandem
- 16.2.26.1. Overview
- 16.2.26.2. Products
- 16.2.26.3. SWOT Analysis
- 16.2.26.4. Recent Developments
- 16.2.26.5. Financials (Based on Availability)
- 16.2.27 4 Other Insulin Device
- 16.2.27.1. Overview
- 16.2.27.2. Products
- 16.2.27.3. SWOT Analysis
- 16.2.27.4. Recent Developments
- 16.2.27.5. Financials (Based on Availability)
- 16.2.28 Insulet Corporation
- 16.2.28.1. Overview
- 16.2.28.2. Products
- 16.2.28.3. SWOT Analysis
- 16.2.28.4. Recent Developments
- 16.2.28.5. Financials (Based on Availability)
- 16.2.1 1 Omnipod
List of Figures
- Figure 1: Global US Diabetes Devices Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: United states US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 3: United states US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 4: North America US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 5: North America US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 6: North America US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 7: North America US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 8: North America US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 9: North America US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: South America US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 11: South America US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 12: South America US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 13: South America US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 14: South America US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 15: South America US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 16: Europe US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 17: Europe US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 18: Europe US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 19: Europe US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 20: Europe US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 21: Europe US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 22: Middle East & Africa US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 23: Middle East & Africa US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 24: Middle East & Africa US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 25: Middle East & Africa US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 26: Middle East & Africa US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 27: Middle East & Africa US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 28: Asia Pacific US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 29: Asia Pacific US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 30: Asia Pacific US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 31: Asia Pacific US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 32: Asia Pacific US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 33: Asia Pacific US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global US Diabetes Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Global US Diabetes Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Northeast US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: Southeast US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Midwest US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Southwest US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: West US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 12: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 13: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 14: United States US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 15: Canada US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Mexico US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 18: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 19: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 20: Brazil US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: Argentina US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Rest of South America US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 24: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 25: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 26: United Kingdom US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 27: Germany US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: France US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 29: Italy US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Spain US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 31: Russia US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: Benelux US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 33: Nordics US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Rest of Europe US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 35: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 36: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 37: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 38: Turkey US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 39: Israel US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: GCC US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 41: North Africa US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: South Africa US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 43: Rest of Middle East & Africa US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 45: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 46: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 47: China US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: India US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 49: Japan US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 50: South Korea US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 51: ASEAN US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 52: Oceania US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 53: Rest of Asia Pacific US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the US Diabetes Devices Market?
The projected CAGR is approximately 6.27%.
2. Which companies are prominent players in the US Diabetes Devices Market?
Key companies in the market include 1 Omnipod, Insulin Devices, 4 Other Continuous Glucose Monitoring Devices, 3 LifeScan, 1 Dexcom, Becton and Dickenson, 3 Abbott, F Hoffmann-La Roche AG, 2 Novo Nordisk, 2 Medtronic, 4 Other Self-monitoring Blood Glucose Devices, Abbott, Self-monitoring Blood Glucose Devices, Novo Nordisk, Eli Lilly and Company*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS, Sanofi, Johnson & Johnson, Ypsomed Holding, Medtronic, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, 2 F Hoffmann-La Roche AG, 3 Johnson & Johnson, Dexcom, 1 Abbott, Continuous Glucose Monitoring Devices, Tandem, 4 Other Insulin Device, Insulet Corporation.
3. What are the main segments of the US Diabetes Devices Market?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 25.16 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring.
6. What are the notable trends driving market growth?
Growing Diabetes and Obesity Population in the United States.
7. Are there any restraints impacting market growth?
Stringent Regulatory Procedures.
8. Can you provide examples of recent developments in the market?
August 2023: The US Food and Drug Administration (FDA) has granted clearance for Roche's Accu-Chek Solo micropump system, a tubing-free "patch" pump for people with diabetes who use insulin.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "US Diabetes Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the US Diabetes Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the US Diabetes Devices Market?
To stay informed about further developments, trends, and reports in the US Diabetes Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
